Collaboration Details

Print  Close

Title of Collaborative Activity:

Registry-based studies of hematologic malignancy incidence and survivorship

Description of Collaborative Activity:

NCI and FDA investigators are collaborating to utilize registry-based data to describe incidence trends of hematologic malignancies as well as second cancer risk and mortality patterns among hematologic malignancy survivors.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: